Telesis Bio Inc. (TBIO)
0.29
0.00 (0.00%)
At close: Mar 28, 2025, 3:55 PM
0.29
0.00%
After-hours: Mar 28, 2025, 03:22 PM EDT
0.00% (1D)
| Bid | 0.29 |
| Market Cap | 514.99K |
| Revenue (ttm) | 13.87M |
| Net Income (ttm) | -46.7M |
| EPS (ttm) | -30.42 |
| PE Ratio (ttm) | -0.01 |
| Forward PE | -0.01 |
| Analyst | n/a |
| Ask | 0.29 |
| Volume | 668 |
| Avg. Volume (20D) | 3,700 |
| Open | 0.29 |
| Previous Close | 0.29 |
| Day's Range | 0.29 - 0.29 |
| 52-Week Range | 0.25 - 8.62 |
| Beta | 1.63 |
About TBIO
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building...
Industry Medical - Devices
Sector Healthcare
IPO Date Jun 18, 2021
Employees 39
Stock Exchange NASDAQ
Ticker Symbol TBIO
Website https://codexdna.com
Next Earnings Release
Telesis Bio Inc. is scheduled to release its earnings on Jan 21, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
6 months ago
+71.98%
Telesis Bio Partners shares are trading higher aft...
Unlock content with
Pro Subscription
6 months ago
-14.39%
Telesis Bio Partners shares are trading higher after the company announced a partnership with Beckman Coulter Life Sciences to revolutionize DNA and mRNA synthesis.
3 years ago · fool.com
Why Translate Bio Stock Soared TodayThe biotech is being bought for $3.2 billion.